These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30776475)

  • 21. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
    Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
    Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Operant procedures for assessing behavioral flexibility in rats.
    Brady AM; Floresco SB
    J Vis Exp; 2015 Feb; (96):e52387. PubMed ID: 25742506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The radical scavenger IAC (bis(1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl) decantionate) decreases mortality, enhances cognitive functions in water maze and reduces amyloid plaque burden in hAβPP transgenic mice.
    Puoliväli J; Nurmi A; Miettinen TK; Soleti A; Riccardino F; Kalesnykas G; Heikkinen T; Vartiainen N; Pussinen R; Tähtivaara L; Lehtimäki K; Yrjänheikki J; Canistro D; Sapone A; Spisni E; Paolini M
    J Alzheimers Dis; 2011; 27(3):499-510. PubMed ID: 21821875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of memory loss in the Tg2576 mouse model of Alzheimer's disease.
    Ashe KH
    J Alzheimers Dis; 2006; 9(3 Suppl):123-6. PubMed ID: 16914850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. M2 Macrophage Transplantation Ameliorates Cognitive Dysfunction in Amyloid-β-Treated Rats Through Regulation of Microglial Polarization.
    Zhu D; Yang N; Liu YY; Zheng J; Ji C; Zuo PP
    J Alzheimers Dis; 2016 Mar; 52(2):483-95. PubMed ID: 27003214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.
    Steffen J; Stenzel J; Ibrahim S; Pahnke J
    J Alzheimers Dis; 2018; 65(2):465-474. PubMed ID: 30040730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
    Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM
    Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.
    Granger MW; Franko B; Taylor MW; Messier C; George-Hyslop PS; Bennett SA
    J Alzheimers Dis; 2016; 51(3):757-73. PubMed ID: 26890738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
    Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
    J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.
    Agca C; Klakotskaia D; Schachtman TR; Chan AW; Lah JJ; Agca Y
    BMC Neurosci; 2016 Jul; 17(1):46. PubMed ID: 27388605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microglial response to amyloid plaques in APPsw transgenic mice.
    Frautschy SA; Yang F; Irrizarry M; Hyman B; Saido TC; Hsiao K; Cole GM
    Am J Pathol; 1998 Jan; 152(1):307-17. PubMed ID: 9422548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
    Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
    J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease.
    Wu K; Gao X; Shi B; Chen S; Zhou X; Li Z; Gan Y; Cui L; Kang JX; Li W; Huang R
    Neuroscience; 2016 Oct; 333():345-55. PubMed ID: 27474225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social housing promotes cognitive function through enhancing synaptic plasticity in APP/PS1 mice.
    Liang F; Yang S; Zhang Y; Hao T
    Behav Brain Res; 2019 Aug; 368():111910. PubMed ID: 31034995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor-γ agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats.
    Lan LF; Zheng L; Yang X; Ji XT; Fan YH; Zeng JS
    CNS Neurosci Ther; 2015 May; 21(5):410-6. PubMed ID: 25611692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.